Dermatology and Therapy

ArticleHistory

received

accepted

first_online

EthicsHeading

Ethics

Codex Labs

Molecules

Br J Dermatol

J Dermatol Treat

J Dermatol

Front Microbiol

Int J Mol Sci

Amino Acids

Acta Dermatovenerol Croat

Clin Cosmet Investig Dermatol

Clin Pharmacol Ther

J Cutan Med Surg

Microorganisms

J Clin Med

Acta Derm Venereol

Klin Med (Mosk)

J Appl Microbiol

Benef Microbes

Nat Rev Immunol

Dermatol Ther (Heidelb)

J Pers Med

Endocr Connect

Front Pharmacol

Int J Cosmet Sci

Nutrients

Nat Methods

Nucleic Acids Res

Singapore Med J

Complement Ther Med

Dermatol Ther

Front Nutr

Cell Commun Signal

Arch Pharm Res

J Immunol

Front Immunol

Dermatology

Indian J Dermatol

J Dermatolog Treat

Int J Endocrinol

Eur Rev Med Pharmacol Sci

Acne pathogenesis is multifactorial, involving systemic factors including gut dysbiosis, hormones, and chronic inflammation. Probiotics, myoinositol, and plant-derived molecules may modulate acne by targeting these factors. The objective is to compare a synbiotic containing herbs against a myoinositol-based herbal supplement on how they influence acne, the gut microbiome, short chain fatty acids (SCFAs), and hormonal profiles.
This was an 8-week, randomized study involving 36 male and female patients aged 12 to 45 years with non-cystic acne. Subjects received either a synbiotic or a myoinositol-based herbal supplement (MBHS). Acne lesions were counted, stool samples were collected for gut microbiome and SCFA analyses, and hormone collections were performed at baseline, 4, and 8 weeks.
Several gut bacteria increased by at least threefold at both week 4 and 8 in the synbiotic (Erysipelatoclostridium merdavium, Blautia argi, Faecalibacterium prausnitzii, Prevotella copri, Streptococcus sp001556435, Blautia sp900541955) and MBHS group (Megamonas funiformis, Ligilactobacillus ruminis, Prevotella ssp015074785, Prevotella copri, Gca-900199835 sp900176495). Acne lesion counts decreased significantly in both groups at week 4 (p < 0.0001) and week 8 (synbiotic, p < 0.0001; MBHS, p < 0.0001). There were significant and trending increases in stool and plasma SCFAs in both cohorts at week 4 and 8. After 8 weeks of MBHS, 17-OHP and androstenedione significantly decreased from 27.3 to 11.3 pg/ml (p = 0.001) and 94.9 to 68.0 pg/ml (p = 0.04), respectively.
Both the synbiotic and MBHS improved gut health, augmented SCFAs, and reduced lesion counts in those with non-cystic acne. The MBHS may act by reducing hormone levels of 17-OHP and androstenedione.
www.
gov (NCT05919810).

Prospective Comparative Study of an Oral Synbiotic and a Myoinositol-Based Herbal Supplement in Modifying Hormone Levels and the Gut Microbiome in Non-cystic Acne.

Prospective Comparative Study of an Oral Synbiotic and a Myoinositol-Based Herbal Supplement in Modifying Hormone Levels and the Gut Microbiome in Non-cystic Acne

Papers